Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

Share Price is delayed by 15 minutes
Get Live Data
3.15    0.00 (0.00%)
Bid:
3.00
Ask:
3.30
Spread: 0.30 (10.00%)
Market Cap: £13.89m
TAVI Live PriceLast checked at - London Stock Exchange

Intraday Tavistock Share Chart

Trading Update

10 May 2016 07:00

RNS Number : 5003X
Tavistock Investments PLC
10 May 2016
 

TAVISTOCK INVESTMENTS PLC

(the "Group" or "Tavistock")

 

TRADING UPDATE

Tavistock is delighted to provide an update on the considerable progress made during the financial year ended 31 March 2016 and post-period to 6 May 2016. The full year results, subject to audit, are expected to be ahead of market expectations.

Group highlights:

· Tavistock now operates an integrated, national business offering both financial advisory and investment management services, with 328 advisers supporting more than 70,000 clients around the UK

· Each of the Group's operating businesses is now trading profitably

· AUI (assets under influence) are estimated to be £4 billion and AUM (assets under management) on either a discretionary or advisory basis exceed £430 million

· As approximately 75% of the Group's net revenues are represented by recurring income, future performance has become significantly more predictable

Tavistock's business model is also gaining increasing commercial traction. In the first half of the financial year ended 31 March 2016, the Group's ongoing businesses reported a small EBITDA loss (excluding share based payment charges and one-off acquisition costs). By contrast, in the second half of the year, the Group's ongoing businesses are expected to report a profit in excess of the first half loss. Consequently, the Group anticipates reporting an EBITDA profit (excluding share based payment charges and one-off acquisition costs) for the year as a whole, which is ahead of market expectations.

Tavistock's recent acquisition of Abacus will significantly enhance the Group's performance in the current financial year and the Board remains committed to the introduction of a dividend stream for the benefit of shareholders within the next 12 months. To ensure the availability of sufficient distributable reserves to pay dividends, the Board plans to begin the Court process of offsetting accumulated losses (principally attributable to the historic discontinued SocialGo business) against the credit balance on the share premium account.

Brian Raven, Group Chief Executive, commented:

"We have made remarkable progress in the two short years since completing our initial transactions, and this would not have been possible without our exceptional management and staff. With more than £9 million of net assets, including cash resources of over £3 million, we are well positioned to capitalise on the opportunities available to us. We look forward to the continuation of our rapid progress in the year ahead."

For further information:

 

Tavistock Investments plc

Oliver Cooke, Executive Chairman

Brian Raven, Group Chief Executive

Tel: 01753 867000

 

 

Northland Capital Partners Limited

William Vandyk

Matthew Johnson

Tel: 020 3861 6625

 

 

WH Ireland Limited

Tim Feather

Liam Gribben

Tel: 0113 394 6600

 

 

Templars Communications Limited

Kitty Parry

Kate Boothman Meier

 

Tel: 020 3642 3140

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLIFFAEAIRIIR
Date   Source Headline
29th May 20269:00 amRNSDirectorate Change
2nd Apr 20267:00 amRNSCompletion of Acquisition
30th Mar 20262:55 pmRNSChange of Auditor
5th Feb 20267:00 amRNSFurther Update on Litigation with Titan
20th Jan 20267:00 amRNSAppointment of Nominated Adviser and Broker
23rd Dec 20257:00 amRNSInterim Results
23rd Dec 20257:00 amRNSInterim Results
17th Dec 202512:13 pmRNSFurther update re ongoing litigation with Titan
16th Dec 20257:00 amRNSUpdate re ongoing litigation with Titan
6th Nov 202512:00 pmRNSResult of AGM
2nd Oct 20257:00 amRNSUpdate re ongoing litigation
30th Sep 20255:00 pmRNSTotal Voting Rights
30th Sep 20257:00 amRNSNotice of AGM
25th Sep 20257:00 amRNSTransfer of Shares from treasury to EBT and TVR
24th Sep 202510:57 amRNSDirector/PDMR Shareholding
18th Sep 20257:00 amRNSFinal Results for the Year Ended 31 March 2025
15th Sep 20252:08 pmRNSHolding(s) in Company
11th Sep 20257:00 amRNSStrategic refocus and acquisition of Lifetime
7th Jul 202512:40 pmRNSDirector / PDMR Dealing
8th Apr 20254:15 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20255:00 pmRNSTotal Voting Rights
20th Feb 20257:00 amRNSCompletion of acquisition of Alpha Beta Partners
14th Feb 202512:08 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSTransaction in Own Shares,Director Dealing and TVR
6th Feb 20252:16 pmRNSDirector/PDMR Shareholding
30th Jan 202511:00 amRNSHolding(s) in Company
30th Jan 20259:53 amRNSHolding(s) in Company
6th Jan 202511:54 amRNSHolding(s) in Company
2nd Jan 20255:45 pmRNSTotal Voting Rights - Replacement
31st Dec 20241:30 pmRNSTotal Voting Rights
12th Dec 202412:00 pmRNSTransaction in Own Shares and Total Voting Rights
11th Dec 202411:30 amRNSResult of AGM
9th Dec 202412:49 pmRNSTransaction in Own Shares and Total Voting Rights
9th Dec 20247:00 amRNSInterim Results
2nd Dec 20247:00 amRNSRepositioning of Retail Asset Management business
22nd Nov 20247:00 amRNSStrategic acquisition and completion of disposal
11th Nov 20243:38 pmRNSNotice of AGM
30th Oct 202411:25 amRNSResult of General Meeting
2nd Oct 20243:50 pmRNSPublication of Circular and Notice of GM
2nd Oct 202411:32 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSProposed disposals for up to £37.75 million
30th Sep 20247:00 amRNSFinal Results for the Year Ended 31 March 2024
19th Sep 20242:47 pmRNSUpdate on Titan Dispute
11th Jul 20247:00 amRNSFollow up to Titan termination announcement
8th Jul 20244:19 pmRNSTermination of strategic partnership
28th Jun 202410:16 amRNSStatement re press speculation
21st Jun 202410:31 amRNSDirectorate Change
31st May 20247:00 amRNSBoard role change
8th Jan 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.